JPMorgan lowered the firm’s price target on Chime (CHYM) to $34 from $40 and keeps an Overweight rating on the shares post the Q3 report. The company’s member growth accelerated and and its margins continue to improve, the analyst tells investors in a research note.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CHYM:
